This article is a Preprint
Preprints are preliminary research reports that have not been certified by peer review. They should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Preprints posted online allow authors to receive rapid feedback and the entire scientific community can appraise the work for themselves and respond appropriately. Those comments are posted alongside the preprints for anyone to read them and serve as a post publication assessment.
Analysis of influenza epidemics in northern China during 2018-2021 and exploration of early diagnosis on influenza B (preprint)
researchsquare; 2023.
Preprint
in English
| PREPRINT-RESEARCHSQUARE | ID: ppzbmed-10.21203.rs.3.rs-2786591.v1
ABSTRACT
Background:
Research on the impacts of COVID-19 towards influenza and the early diagnosis of influenza B is limited. This study aimed to analyze the impacts of COVID-19 pandemic on influenza epidemics in northern China and explore the early-diagnosis indicators of influenza B.Methods:
1. Data of influenza-like illness (ILI) and influenza virological surveillance in northern China during 2018-2021 winter influenza season were collected to analyze the impacts of COVID-19 pandemic on influenza epidemics. 2. Clinical characteristics of 38 influenza B positive patients and 38 influenza B negative patients confirmed during 2021 winter influenza season were retrospectively observed. Clinical symptoms and blood routine indicators of both groups were compared and analyzed.Results:
1. During 2020 and 2021 winter influenza season, ILI% and influenza virus positive rate in northern China were both lower than those in 2018 and 2019, with the influenza B (Victoria) dominating. 2. Compared with influenza B negative group, the systemic symptoms in influenza B positive group were significantly increased. The value of white blood cell, neutrophils%, C-reactive protein and serum amyloid A in influenza B positive group were significantly lower than those in negative group, while the lymphocytes% and monocytes% were higher than those in negative group and both could be regarded as the diagnostic indicators of influenza B.Conclusions:
Influenza epidemics were greatly reduced during COVID-19 pandemic, with influenza B rebounding from 2021, and continuous surveillance is still needed. Both clinical features and blood routine indicators can be helpful towards the early diagnosis on influenza B.
Full text:
Available
Collection:
Preprints
Database:
PREPRINT-RESEARCHSQUARE
Main subject:
COVID-19
Language:
English
Year:
2023
Document Type:
Preprint
Similar
MEDLINE
...
LILACS
LIS